Cargando…
Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Liver Cancer Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565551/ https://www.ncbi.nlm.nih.gov/pubmed/37680020 http://dx.doi.org/10.17998/jlc.2023.08.18 |
| _version_ | 1785118719406505984 |
|---|---|
| author | Bae, Sun Hyun Park, Hee Chul |
| author_facet | Bae, Sun Hyun Park, Hee Chul |
| author_sort | Bae, Sun Hyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10565551 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Liver Cancer Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105655512023-10-12 Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” Bae, Sun Hyun Park, Hee Chul J Liver Cancer Letter to the Editor The Korean Liver Cancer Association 2023-09 2023-09-08 /pmc/articles/PMC10565551/ /pubmed/37680020 http://dx.doi.org/10.17998/jlc.2023.08.18 Text en © 2023 The Korean Liver Cancer Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Bae, Sun Hyun Park, Hee Chul Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title | Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title_full | Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title_fullStr | Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title_full_unstemmed | Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title_short | Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| title_sort | letter regarding “feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565551/ https://www.ncbi.nlm.nih.gov/pubmed/37680020 http://dx.doi.org/10.17998/jlc.2023.08.18 |
| work_keys_str_mv | AT baesunhyun letterregardingfeasibilityofadditionalradiotherapyinpatientswithadvancedhepatocellularcarcinomatreatedwithatezolizumabplusbevacizumab AT parkheechul letterregardingfeasibilityofadditionalradiotherapyinpatientswithadvancedhepatocellularcarcinomatreatedwithatezolizumabplusbevacizumab |